Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adlette Inati

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Hemoglobin|November 13, 2007
Febrile neutropenia and hemorrhagic stroke in a thalassemia major patientMarwan Sheikh-Taha, Suzane Koussa, Adlette Inati, et al.
American Journal of Hematology|April 3, 2008
Complications of beta-thalassemia intermedia: a 12-year Lebanese experienceAli Taher, Fuad El Rassi, Hussain Ismaeel, et al.
Biomed Research International|April 3, 2015
Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatmentAdlette Inati, MohammadHassan A Noureldine, Anthony Mansour, et al.
Pediatric Annals|March 6, 2013
A review of acute chest syndrome in pediatric sickle cell diseaseHussein A Abbas, Mario Kahale, Maen Aboul Hosn, et al.
American Journal of Hematology|August 20, 2010
Iron chelation therapy for patients with sickle cell disease and iron overloadAdlette Inati, Evelyne Khoriaty, Khaled M Musallam, et al.
Pediatric Annals|June 12, 2008
Beta-thalassemia intermedia: an overviewFuad El Rassi, Maria Domenica Cappellini, Adlette Inati, et al.
Annals of Hematology|May 6, 2009
Transfusion independence in Diamond-Blackfan anemia after deferasirox therapyAli T Taher, Khaled M Musallam, Suzane Koussa, et al.
Blood|April 10, 2010
Iron overload indices rise linearly with transfusion rate in patients with sickle cell diseaseAdlette Inati, Khaled M Musallam, John C Wood, et al.
Journal of Gastroenterology and Hepatology|July 11, 2006
Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2bAla I Sharara, Elie Aoun, Suzanne Koussa, et al.
Research and Practice in Thrombosis and Haemostasis|April 14, 2025
Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysisRobert F Sidonio, Leonid Dubey, Kateryna V Vilchevska, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Hemoglobin|November 13, 2007
Febrile neutropenia and hemorrhagic stroke in a thalassemia major patientMarwan Sheikh-Taha, Suzane Koussa, Adlette Inati, et al.
American Journal of Hematology|April 3, 2008
Complications of beta-thalassemia intermedia: a 12-year Lebanese experienceAli Taher, Fuad El Rassi, Hussain Ismaeel, et al.
Biomed Research International|April 3, 2015
Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatmentAdlette Inati, MohammadHassan A Noureldine, Anthony Mansour, et al.
Pediatric Annals|March 6, 2013
A review of acute chest syndrome in pediatric sickle cell diseaseHussein A Abbas, Mario Kahale, Maen Aboul Hosn, et al.
American Journal of Hematology|August 20, 2010
Iron chelation therapy for patients with sickle cell disease and iron overloadAdlette Inati, Evelyne Khoriaty, Khaled M Musallam, et al.
Pediatric Annals|June 12, 2008
Beta-thalassemia intermedia: an overviewFuad El Rassi, Maria Domenica Cappellini, Adlette Inati, et al.
Annals of Hematology|May 6, 2009
Transfusion independence in Diamond-Blackfan anemia after deferasirox therapyAli T Taher, Khaled M Musallam, Suzane Koussa, et al.
Blood|April 10, 2010
Iron overload indices rise linearly with transfusion rate in patients with sickle cell diseaseAdlette Inati, Khaled M Musallam, John C Wood, et al.
Journal of Gastroenterology and Hepatology|July 11, 2006
Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2bAla I Sharara, Elie Aoun, Suzanne Koussa, et al.
Research and Practice in Thrombosis and Haemostasis|April 14, 2025
Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysisRobert F Sidonio, Leonid Dubey, Kateryna V Vilchevska, et al.
Pageof 7